BCL2 Mouse Monoclonal Antibody [Clone ID: OTI9D3] TA806591 from OriGene Technologies

Product Specs
ItemBCL2 Mouse Monoclonal Antibody [Clone ID: OTI9D3]
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberTA806591
Quantity100 µl
ApplicationsIHC, WB
Concentration1 mg/ml
ReactivityHuman, Mouse, Rat
TargetBCL2
IsotypeIgG2b
CloneOTI9D3
HostMouse
Antibody TypePrimary Antibodies
ImmunogenFull length human recombinant protein of human BCL2 (NP_000624) produced in HEK293T cell
ClonalityMonoclonal
PurityPurified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
NCBI Full Gene NameBCL2 apoptosis regulator
NCBI Gene AliasesBcl-2, PPP1R50
Conjugate/TagUnconjugated
TypePrimary Antibodies
FormatPBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

(1) 3‑Bromopyruvic acid regulates glucose metabolism by targeting the c‑Myc/TXNIP axis and induces mitochondria‑mediated apoptosis in TNBC cellsExperimental and Therapeutic MedicineJune 16, 2022Jiachen Li, Jianmin Pan, Yang Liu, Xiaohui Luo, Cheng Yang, Wangfa Xiao, Qishang Li, Lihui Yang, Xiaodong ZhangOriGene Technologies, Inc.), HK2 (1:1,000; cat. no. TA500856; OriGene Technologies, Inc.), Bcl-2 (1:2,000; cat. no. TA806591; OriGene Technologies, Inc.), Bax (1:2,000; cat. no. TA810334; OriGene Technologies, Inc.), cytochrome

(2) Shikonin protects against lipopolysaccharide‐induced inflammation and apoptosis in human nucleus pulposus cells through the nuclear factor‐kappa B pathwayFood Science & NutritionOctober 1, 2021Yuanbin Liu, Jiazhuang Zheng, Yu Chen, Fandong Wang, He Ye, Miao Wang, Zhi Zhanganti‐P65, #8242, CST; anti‐cleave caspase 3, #9664, CST; anti‐Bax, TA810334, OriGene; and anti‐Bcl‐2, TA806591, OriGene) at 4°C overnight. The membrane was incubated with the corresponding secondary antibody for

(4) Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpuraJournal of nephrologyOctober 1, 2018Milillo A, Molinario C, Costanzi S, Vischini G, La Carpia F, La Greca F, Rigante D, Gambaro G, Gurrieri F, Sangiorgi E.

Experimental and Therapeutic Medicine